US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 2.940
  • +0.017+0.59%
Trading Nov 22 12:15 ET
15.98MMarket Cap-1050P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aprea Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q3354.620K / 150.000K--
--2024/Q2561.570K / 33.330K--
--2024/Q1380.570K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q3354.620K / 150.000K--
--2024/Q2561.570K / 33.330K--
--2024/Q1380.570K / 0.000--

Unlock Free Earnings Estimates

Aprea Therapeutics Earnings Reports

  • Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 7 21:43

  • Aprea Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 21:38

  • Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 12 20:46

  • Aprea Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 20:40

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 13, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data